Implantation Testing

The development of implantable medical devices requires rigorous evaluation to ensure their safety and biocompatibility within the human body. Implantation testing is a critical preclinical assessment that evaluates the local tissue response to a device after surgical placement in an animal model. This test is essential for regulatory submissions, including FDA 510(k), PMA, EU MDR, and other global approvals, as it provides key data on potential inflammation, fibrosis, necrosis, or other adverse reactions. Regulatory bodies worldwide mandate implantation studies to demonstrate biocompatibility and ensure patient safety before clinical use. At Meditronics (a brand of STEMart), we offer comprehensive implantation testing services to support your device's biocompatibility and compliance with international standards.

2-1-9-implantation-testing-1(generated by AI)

Our Service

Meditronics's implantation testing strictly follows ISO 10993-6, which defines protocols for evaluating tissue reactions to implanted materials. The study involves surgical implantation in appropriate animal models, followed by histopathological analysis to assess biocompatibility:

work flow (made by Meditronics)

1. Animal Model Selection:

Rabbits/Rats/Mice: Commonly used for general biocompatibility testing.

Pigs/Sheep/Dogs: Preferred for large or long-term implants (e.g., cardiovascular stents, orthopedic devices).

2. Implantation Method:

Intramuscular (IM): Evaluates systemic biocompatibility (e.g., pacemakers).
Subcutaneous (SC): Assesses soft tissue response (e.g., sutures, dermal fillers).
Bone Implantation: For orthopedic/dental implants (e.g., screws, bone grafts).

3. Implantation Duration:

Short-term (1-4 weeks): Acute inflammatory response.
Long-term (12-52 weeks): Chronic reactions, encapsulation, or degradation.

4. Post-Implantation Evaluation

Gross Necropsy Observations: Macroscopic assessment of implant sites for inflammation, hemorrhage, or encapsulation.
Histopathology Review: Microscopic analysis of tissue sections to identify:
- Fibrosis, necrosis, or foreign body giant cells.
- Inflammatory cell infiltration (lymphocytes, macrophages).
- Tissue integration or material degradation.

All studies are conducted under GLP (Good Laboratory Practice) conditions, ensuring reproducibility and regulatory acceptance.

Why Choose Meditronics

Meditronics provides fully accredited implantation testing services compliant with FDA (21 CFR Part 58), EU MDR (Annex XIV), ISO 10993-6, and other global regulations. We support medical device companies in achieving fast-track approvals through scientifically robust and regulatory-aligned testing.

✔ Expert Surgical Team

Highly skilled in implant procedures across diverse animal models, ensuring precision and consistency.

✔ Toxicology & Pathology Specialists

In-depth analysis of tissue responses with actionable insights for risk mitigation.

✔ Customized Testing Solutions

Tailored protocols based on device type, material, and intended use (e.g., absorbable vs. non-absorbable implants).

✔ End-to-End Regulatory Support

From study design to final reports, we prepare submission-ready documentation for FDA, CE, NMPA, and other agencies.

By partnering with Meditronics, manufacturers gain reliable, high-quality data that accelerates market entry while ensuring patient safety. Contact us today to discuss your custom implantation testing needs and streamline your regulatory pathway!

Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Need More Information or Request A Quotation?

Send us a request